Download PDF
CC BY-NC-ND 4.0 · Ann Natl Acad Med Sci 2017; 53(01): 030-035
DOI: 10.1055/s-0040-1712742
Original Article

Neurodevelopmental Disorders: The Journey, the Dreams and their Realization

Sheffali Gulati
Child Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints

ABSTRACT

Neuro Developmental Disorders (NDDs) are associated with significant morbidity. This involves early identification of the disorder, the correct management of the disorder and associated disabilities. In India, the paucity of trained personnel and lack of knowledge about these disorders has been instrumental in inadequate management and recognition of these NDDs. The Child Neurology Division, Department of Pediatrics at All India Institute of Medical Sciences has made few noteworthy and meaningful contributions in these aspects: devising a DM curriculum for pediatric neurology, developing indigenous tools for diagnosing these NDDs and performing relevant research. These endeavors would go a long way in serving the children with NDDs.

Keywords

Neurodevelopmental disorders - autism - cerebral palsy - attention deficit hyperactivity disorder


Publication History

Article published online:
08 May 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Sharma S, Gulati S, Kalra V, Agarwala A, Kabra M (2009). Seizure control and biochemical profile on the ketogenic diet in young children with refractory epilepsy-Indian experience. Seizure 18(6):446-449.
  • 2 Kim JA, Yoon JR, Lee EJ, et al (2016). Efficacy of the classic ketogenic and the modified Atkins diets in refractory childhood epilepsy. Epilepsia 57(1):51
  • 3 Raju KN, Gulati S, Kabra M,, et al (2011). Efficacy of 4:1 (classic) versus 2.5:1 ketogenic ratio diets in refractory epilepsy in young children: a randomized open labeled study. Epilepsy Res 96(1-2):96
  • 4 Sharma S, Gulati S (2012). The ketogenic diet and the QT interval. J Clin Neurosci 19(1):181-182.
  • 5 Sharma S, Sankhyan N, Gulati S, Agarwala A (2012). Use of the modified Atkins diet in infantile spasms refractory to first-line treatment. Seizure 21(1):45
  • 6 Sharma S, Sankhyan N, Gulati S, Agarwala A (2013). Use of the modified Atkins diet for treatment of refractory childhood epilepsy: a randomized controlled trial. Epilepsia 54(3):481-486.
  • 7 Sharma S, Jain P, Gulati S, Sankhyan N, Agarwala A (2015). Use of the modified Atkins diet in Lennox Gastaut syndrome. J Child Neurol 30(5):576-579.
  • 8 Pandit AK, Ihtisham K, Garg A, Gulati S, Padma MV, Tripathi M (2013). Autoimmune encephalitis: A potentially reversible cause of status epilepticus, epilepsy, and cognitive decline. Ann Indian Acad Neurol 16(4):577-584.
  • 9 Gulati S, Jain P, Chakrabarty B, Kumar A, Gupta N, Kabra M (2016). The spectrum of leukodystrophies in children: Experience at a tertiary care centre from North India. Ann Indian Acad Neurol 19(3):332-338.
  • 10 Gulati S, Chakrabarty B, Kumar A, et al (2015). Acquired demyelinating disorders of central nervous system: A pediatric cohort. Ann Indian Acad Neurol 18(Suppl 1):S48-S55.
  • 11 Bhattacharyya M, Kalra V, Gulati S (2006). Intranasal midazolam vs rectal diazepam in acute childhood seizures. Pediatr Neurol 34(5):355-359.
  • 12 Anonymous. (2014). Setting up district early intervention centres: Operational Guidelines. Rashtriya Bal Swasthya Karyakam, Child Health Screening and Early Intervention Services under NHM. New Delhi: Ministry of Health & Family Welfare, GoI.
  • 13 Anonymous (2014). Patient Education Booklet. New Delhi : All India Institute of Medical Sciences.
  • 14 Gulati S, Aneja S, Juneja M, et al (2014). INCLEN Diagnostic Tool for Neuromotor Impairments (INDT-NMI) for primary care physician: development and validation. Indian Pediatr 51(8):613-619.
  • 15 Juneja M, Mishra D, Russell PS, et al (2014). INCLEN Diagnostic Tool for Autism Spectrum Disorder (INDT-ASD): development and validation. Indian Pediatr 51(5):359-365.
  • 16 Konanki R, Mishra D, Gulati S, et al (2014). INCLEN Diagnostic Tool for Epilepsy (INDT-EPI) for primary care physicians: development and validation. Indian Pediatr 51(7):539-543.
  • 17 Mukherjee S, Aneja S, Russell PS, et al (2014). INCLEN diagnostic tool for attention deficit hyperactivity disorder (INDT-ADHD): development and validation. Indian Pediatr 51(6):457-462.
  • 18 Tanveer NO, Sharma MC, Sarkar C, et al (2009). Diagnostic utility of skin biopsy in dystrophinopathies. Clin Neurol Neurosurg 111(6):496-502.
  • 19 Chakrabarty B, Sharma MC, Gulati S, et al (2014). Skin biopsy: a new tool to diagnose sarcoglycanopathy. J Child Neurol 29(8):NP5-8.
  • 20 Chakrabarty B, Sharma MC, Gulati S, et al (2014). Dystrophinopathy diagnosis made easy: skin biopsy, an emerging novel tool. J Child Neurol 29(4):469-474.